CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 10-Q Report Quarterly Report
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Director sold 8,560 shares at $3.05 ($26,108)
- 144 Insider Sale of Securities
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Director sold 10,805 shares at $3.50 ($37,827)
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO & President acquired 149,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Option exercise CEO & President acquired 41,506 shares (option exercise)
- 4 Open-market sale Director sold 10,984 shares at an average $6.13 ($67,288)
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
Page 9 of 26 · 511 filings